{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:40:59Z","timestamp":1760146859046,"version":"build-2065373602"},"reference-count":21,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cheng Kung University Hospital","award":["NCKUH-11109022"],"award-info":[{"award-number":["NCKUH-11109022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Objectives: We aim to study the relative viral load using salivary polymerase chain reaction among pregnant women treated with Paxlovid. Methods: Pregnant women with coronavirus disease 2019 were allocated to two groups: those receiving Paxlovid and those receiving no antiviral agents. We compared the nasopharyngeal and salivary relative viral loads and their changes in saliva specimens. Results: Among the thirty-seven pregnant women, seventeen received Paxlovid, and twenty received no antiviral agents. The viral cycle threshold value of saliva was significantly higher than that from nasopharynx, with a median \u00b1 interquartile range of 26.44 \u00b1 7.68 versus 17.6 \u00b1 9.6 in the Paxlovid group (p = 0.005). Following treatment, the median salivary viral load decreased by 13.40 cycle threshold values in the Paxlovid group (from a median of [Day 0 Ct] to [Day 4\/5 Ct]), compared to a change of \u22121.59 cycle threshold values in the no-antiviral group (from a median of [Day 0 Ct] to [Day 4\/5 Ct]) (p = 0.021). The detection rate of coronavirus disease 2019 using salivary polymerase chain reaction was 83.8% (31\/37). Conclusions: This study showed that saliva is a useful diagnostic tool for coronavirus disease 2019 in pregnant women, and a significant decrease in the relative viral load of saliva was observed in those treated with Paxlovid.<\/jats:p>","DOI":"10.3390\/microorganisms12122566","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T10:53:27Z","timestamp":1734000807000},"page":"2566","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Pregnant Women Treated with Nirmatrelvir\/Ritonavir (Paxlovid) Using Salivary Polymerase Chain Reaction: A Prospective Cohort Study"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5962-4605","authenticated-orcid":false,"given":"Chun-Han","family":"Tseng","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng-Li Road, Tainan 704, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5353-639X","authenticated-orcid":false,"given":"Chih-Wei","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng-Li Road, Tainan 704, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Yin","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng-Li Road, Tainan 704, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Tsz","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng-Li Road, Tainan 704, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/jog.14321","article-title":"Clinical update on COVID-19 in pregnancy: A review article","volume":"46","author":"Ryan","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study","volume":"20","author":"To","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e28441","DOI":"10.1002\/jmv.28441","article-title":"Efficacy and safety of nirmatrelvir\/ritonavir (Paxlovid) for COVID-19: A rapid review and meta-analysis","volume":"95","author":"Amani","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with COVID-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cmi.2018.06.009","article-title":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: A diagnostic validity study","volume":"25","author":"To","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jviromet.2017.01.013","article-title":"The use of saliva specimens for detection of influenza A and B viruses by rapid influenza diagnostic tests","volume":"243","author":"Yoon","year":"2017","journal-title":"J. Virol. Methods."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/JCM.01704-16","article-title":"Comparison between Saliva and Nasopharyngeal Swab Specimens for Detection of Respiratory Viruses by Multiplex Reverse Transcription-PCR","volume":"55","author":"Kim","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1038\/emi.2017.35","article-title":"Additional molecular testing of saliva specimens improves the detection of respiratory viruses","volume":"6","author":"To","year":"2017","journal-title":"Emerg. Microbes Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/cid\/ciaa149","article-title":"Consistent Detection of 2019 Novel Coronavirus in Saliva","volume":"71","author":"To","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","unstructured":"National Institutes of Health (2024, October 15). COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines, Available online: https:\/\/covid19.nih.gov\/covid-19-information."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kritikos, A., Caruana, G., Lazor-Blanchet, C., Currat, M., Chiche, J.-D., Vollenweider, P., Bart, P.-A., Opota, O., and Greub, G. (2022). Comparison of Nasopharyngeal and Saliva Swab Nucleic Acid Amplification and Rapid Antigen Testing To Detect Omicron SARS-CoV-2 Variant of Concern: A Prospective Clinical Trial (OMICRON). Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.03923-22"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/JCM.02881-20","article-title":"Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: A Systematic Review and Meta-analysis","volume":"59","author":"Lee","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Migueres, M., Mansuy, J.-M., Vasseur, S., Claverie, N., Lougarre, C., Soulier, F., Tr\u00e9meaux, P., and Izopet, J. (2022). Omicron Wave SARS-CoV-2 Diagnosis: Evaluation of Saliva, Anterior Nasal, and Nasopharyngeal Swab Samples. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.02521-22"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Beyene, G.T., Alemu, F., Kebede, E.S., Alemayehu, D.H., Seyoum, T., Tefera, D.A., Assefa, G., Tesfaye, A., Habte, A., and Bedada, G. (2021). Saliva is superior over nasopharyngeal swab for detecting SARS-CoV2 in COVID-19 patients. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-02097-2"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yu, F., Xie, G., Zheng, S., Han, D., Bao, J., Zhang, D., Feng, B., Wang, Q., Zou, Q., and Wang, R. (2021). Assessment of the Diagnostic Ability of Four Detection Methods Using Three Sample Types of COVID-19 Patients. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.685640"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jama.2021.13967","article-title":"Change in Saliva RT-PCR Sensitivity Over the Course of SARS-CoV-2 Infection","volume":"326","author":"Lee","year":"2021","journal-title":"Jama"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jamainternmed.2020.8876","article-title":"Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis","volume":"181","author":"Lawandi","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S1473-3099(22)00507-2","article-title":"Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong\u2019s omicron BA.2 wave: A retrospective cohort study","volume":"22","author":"Wong","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.jiph.2023.10.007","article-title":"Clinical outcomes of nirmatrelvir-ritonavir use in pregnant women during the Omicron wave of the coronavirus disease 2019 pandemic","volume":"16","author":"Lin","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41591-023-02674-0","article-title":"Nirmatrelvir\/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection: A target trial emulation","volume":"30","author":"Wong","year":"2023","journal-title":"Nat. Med."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/12\/2566\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:53:48Z","timestamp":1760115228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/12\/2566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":21,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["microorganisms12122566"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms12122566","relation":{},"ISSN":["2076-2607"],"issn-type":[{"type":"electronic","value":"2076-2607"}],"subject":[],"published":{"date-parts":[[2024,12,12]]}}}